MeSH D020739 - metabolic brain diseases inborn
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D020739:
Metabolic brain diseases inborn
0 Companies
0 Drugs
Success rate
D005693:Galactosemias
0 Companies
0 Drugs
Success rate
D006250:Hartnup disease
0 Companies
0 Drugs
Success rate
D006527:Hepatolenticular degeneration
D006712:Homocystinuria
D007706:Menkes kinky hair syndrome
0 Companies
0 Drugs
Success rate
D007888:Leigh disease
0 Companies
0 Drugs
Success rate
D007926:Lesch-nyhan syndrome
0 Companies
0 Drugs
Success rate
D008375:Maple syrup urine disease
0 Companies
0 Drugs
Success rate
D009800:Oculocerebrorenal syndrome
0 Companies
0 Drugs
Success rate
D010661:Phenylketonurias
D012035:Refsum disease
0 Companies
0 Drugs
Success rate
D015211:Zellweger syndrome
D015324:Pyruvate carboxylase deficiency disease
0 Companies
0 Drugs
Success rate
D015325:Pyruvate dehydrogenase complex deficiency disease
0 Companies
0 Drugs
Success rate
D017241:Melas syndrome
0 Companies
0 Drugs
Success rate
D017243:Merrf syndrome
0 Companies
0 Drugs
Success rate
D020140:Nervous system lysosomal storage diseases
0 Companies
0 Drugs
Success rate
D020158:Nonketotic hyperglycinemia
0 Companies
0 Drugs
Success rate
D020167:Hyperlysinemias
0 Companies
0 Drugs
Success rate
D020176:Tyrosinemias
D020279:Hereditary central nervous system demyelinating diseases
0 Companies
0 Drugs
Success rate
D028243:Familial cerebral amyloid angiopathy
0 Companies
0 Drugs
Success rate
D052919:Infantile refsum disease
0 Companies
0 Drugs
Success rate
Events Timeline
Commercial
No Data
Clinical Trials
Historical Success Rate
Phase 1
0%0/0
Phase 2
0%0/7
Phase 3
0%0/0
Approved: 0Overall Success rate: 0%
All Clinical Trials
No data
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use